Glucose-lowering treatment pathways of individuals with chronic kidney disease and type 2 diabetes according to the Kidney Disease: Improving Global Outcomes 2012 risk classification.

Carol PollockJuan Jose Garcia SanchezJuan-Jesus CarreroSupriya KumarRoberto Pecoits-FilhoCarolyn S P LamHungta ChenEiichiro KandaMitja LainscakDavid Collins Wheeler

Published in: Diabetic medicine : a journal of the British Diabetic Association (2023)

Individuals with CKD and T2D had many combinations of therapies and substantial follow-up time on therapy. These results highlight opportunities for improved CKD management.

Keyphrases

chronic kidney disease
end stage renal disease
type diabetes
machine learning
glycemic control
deep learning
cardiovascular disease
insulin resistance
combination therapy
mesenchymal stem cells